Background: Ecto/nucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) loss-of-function mutations have been described in patients with autosomal recessive hypophosphatemic rickets (HR), in patients with generalized arterial calcification of infancy (GACI) and in several patients with both conditions. Out of more than 50 cases of homozygous or compound heterozygous ENPP1 loss-of-function mutations published so far, 1 case with labyrinthine deafness probably due to occlusion of inner ear supplying arteries and 2 cases of conductive hearing loss due to stapedovestibular calcification diagnosed in childhood have been reported. Aims: To report a case of ENPP1 loss-of-function novel mutation presenting with HR and very early onset and severe hearing loss. Methods: Case report and review of the literature. Results: We report on a patient homozygous for a novel 1-bp deletion in ENPP1 that presented with GACI evolving towards HR associated with a mixed hearing loss (both labyrinthine and conductive) diagnosed at 9 days of life that evolved towards profound labyrinthine deafness. Conclusion: Hearing loss is a rare finding in patients with ENPP1 loss-of-function mutations. Interestingly, it has already been described in other affected patients, in ENPP1 knock-out mice and in other diseases of pyrophosphate metabolism. Conversely it seems to be absent in children with the X-linked form of HR.

1.
Rutsch F, Ruf N, Vaingankar S, Toliat MR, Suk A, Höhne W, et al: Mutations in ENPP1 are associated with ‘idiopathic' infantile arterial calcification. Nat Genet 2003;34:379-381.
2.
Ruf N, Uhlenberg B, Terkeltaub R, Nürnberg P, Rutsch F: The mutational spectrum of ENPP1 as arising after the analysis of 23 unrelated patients with generalized arterial calcification of infancy. Hum Mutat 2005;25:98-98.
3.
Cheng KS, Chen MR, Ruf N, Lin SP, Rutsch F: Generalized arterial calcification of infancy: different clinical courses in two affected siblings. Am J Med Genet 2005;136A:210-213.
4.
Ciana G, Trappan A, Bembi B, Benettoni A, Maso G, Zennaro F, et al: Generalized arterial calcification of infancy: two siblings with prolonged survival. Eur J Pediatr 2005;165:258-263.
5.
Numakura C, Yamada M, Ariyasu D, Maesaka A, Kobayashi H, Nishimura G, et al: Genetic and enzymatic analysis for two Japanese patients with idiopathic infantile arterial calcification. J Bone Miner Metab 2005;24:48-52.
6.
Lorenz-Depiereux B, Schnabel D, Tiosano D, Häusler G, Strom TM: Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet 2010;86:267-272.
7.
Galletti S, Nitschke Y, Malavolti AM, Aquilano G, Faldella G, Corvaglia L, et al: Generalized arterial calcification of infancy: fatal clinical course associated with a novel mutation in ENPP1; in Society for the Study of Inborn Errors: JIMD Reports - Case and Research Reports, 2011/1. Berlin, Springer, 2011, pp 23-27.
8.
Edouard T, Chabot G, Miro J, Buhas DC, Nitschke Y, Lapierre C, et al: Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy. Eur J Pediatr 2011;170:1585-1590.
9.
Nitschke Y, Baujat G, Botschen U, Wittkampf T, du Moulin M, Stella J, et al: Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet 2012;90:25-39.
10.
Fishman G, Miller-Hansen D, Jacobsen C, Singhal V, Alon U: Hearing impairment in familial X-linked hypophosphatemic rickets. Eur J Pediatr 2004;163:622-623.
11.
Meister M, Johnson A, Popelka GR, Kim GS, Whyte MP: Audiologic findings in young patients with hypophosphatemic bone disease. Ann Otol Rhinol Laryngol 1986;95:415-420.
12.
Davies M, Kane R, Valentine J: Impaired hearing in X-linked hypophosphataemic (vitamin-D-resistant) osteomalacia. Ann Intern Med 1984;100:230-232.
13.
Stamp TC, Baker LR: Recessive hypophosphataemic rickets, and possible aetiology of the ‘vitamin D-resistant' syndrome. Arch Dis Child 1976;51:360-365.
14.
Weir N: Sensorineural deafness associated with recessive hypophosphataemic rickets. J Laryngol Otol 1977;91:717-722.
15.
Beighton P, Hamersma H, Horan F: Craniometaphyseal dysplasia - variability of expression within a large family. Clin Genet 1979;15:252-258.
16.
Morava E, Kühnisch J, Drijvers JM, Robben JH, Cremers C, van Setten P, et al: Autosomal recessive mental retardation, deafness, ankylosis, and mild hypophosphatemia associated with a novel ANKH mutation in a consanguineous family. J Clin Endocrinol Metab 2011;96:E189-E198.
17.
Harris BS, et al: Ages with stiffened joints, a new mutation in ENPP1. MGI Direct Data Submission, 2011.
18.
Okawa A, Nakamura I, Goto S, Moriya H, Nakamura Y, Ikegawa S: Mutation in NPPS in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat Genet 1998;19:271-273.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.